| 标题 |
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial 舒格利单抗与安慰剂联合铂类化疗一线治疗转移性非小细胞肺癌(GEMSTONE-302)的比较:一项双盲、随机、3期试验的4年结果
|
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:Caicun Zhou; Ziping Wang; Meili Sun; Lejie Cao; Zhiyong Ma; et al 出版日期:2025 |
| 求助人 | |
| 下载 |